|1.||Potter, Barry V L: 3 articles (11/2011 - 08/2008)|
|2.||Woo, L W Lawrence: 3 articles (11/2011 - 08/2008)|
|3.||Purohit, Atul: 3 articles (11/2011 - 08/2008)|
|4.||Ganeshapillai, Dharshini: 1 article (11/2011)|
|5.||Mahon, Mary F: 1 article (11/2011)|
|6.||Thomas, Mark P: 1 article (11/2011)|
|7.||Sutcliffe, Oliver B: 1 article (11/2011)|
|8.||Malini, Bindu: 1 article (11/2011)|
|9.||Stanway, Susie: 1 article (02/2011)|
|10.||Januszewski, Adam: 1 article (02/2011)|
|1.||Endometrial Neoplasms (Endometrial Cancer)
07/04/2011 - "This timely review therefore concentrates on recent advances in steroid sulfatase research, and summarises the findings of clinical trials with Irosustat (BN83495), the only steroid sulfatase inhibitor that is being trialed in postmenopausal women with breast or endometrial cancer."
08/01/2008 - "This study investigates the effects of STX64 (also known as 667Coumate and BN83495) and STX213, two potent STS inhibitors, on hormone-dependent endometrial cancer cell growth in vivo. "
|3.||Breast Neoplasms (Breast Cancer)
02/01/2011 - "In this article, we summarize the preclinical and clinical data to support the potential role of steroid sulfatase in breast cancer, as well as the current data on the first available steroid sulfatase inhibitor named irosustat (STX64; 667 Coumate; BN83495), and discuss its potential clinical development."
|1.||Steryl-Sulfatase (Steroid Sulfatase)